242 related articles for article (PubMed ID: 9087426)
1. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.
Lundgren K; Montes de Oca Luna R; McNeill YB; Emerick EP; Spencer B; Barfield CR; Lozano G; Rosenberg MP; Finlay CA
Genes Dev; 1997 Mar; 11(6):714-25. PubMed ID: 9087426
[TBL] [Abstract][Full Text] [Related]
2. Loss of p19ARF enhances the defects of Mdm2 overexpression in the mammary gland.
Foster CJ; Lozano G
Oncogene; 2002 May; 21(22):3525-31. PubMed ID: 12032854
[TBL] [Abstract][Full Text] [Related]
3. Overproduction of MDM2 in vivo disrupts S phase independent of E2F1.
Reinke V; Bortner DM; Amelse LL; Lundgren K; Rosenberg MP; Finlay CA; Lozano G
Cell Growth Differ; 1999 Mar; 10(3):147-54. PubMed ID: 10099828
[TBL] [Abstract][Full Text] [Related]
4. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
5. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.
Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
Cell Growth Differ; 1996 Jan; 7(1):3-11. PubMed ID: 8788028
[TBL] [Abstract][Full Text] [Related]
6. Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis.
Cheng X; Xia W; Yang JY; Hsu JL; Lang JY; Chou CK; Du Y; Sun HL; Wyszomierski SL; Mills GB; Muller WJ; Yu D; Hung MC
Cancer Res; 2010 Oct; 70(19):7684-9. PubMed ID: 20841468
[TBL] [Abstract][Full Text] [Related]
7. Developmental regulation of the ovine beta-lactoglobulin/human serum albumin transgene is distinct from that of the beta-lactoglobulin and the endogenous beta-casein genes in the mammary gland of transgenic mice.
Baruch A; Shani M; Hurwitz DR; Barash I
Dev Genet; 1995; 16(3):241-52. PubMed ID: 7796533
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.
Jones SN; Hancock AR; Vogel H; Donehower LA; Bradley A
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15608-12. PubMed ID: 9861017
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis.
Bortner DM; Rosenberg MP
Cell Growth Differ; 1995 Dec; 6(12):1579-89. PubMed ID: 9019163
[TBL] [Abstract][Full Text] [Related]
10. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
[TBL] [Abstract][Full Text] [Related]
12. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation.
Howe LR; Watanabe O; Leonard J; Brown AM
Cancer Res; 2003 Apr; 63(8):1906-13. PubMed ID: 12702582
[TBL] [Abstract][Full Text] [Related]
13. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
[TBL] [Abstract][Full Text] [Related]
14. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.
Gottlieb E; Haffner R; King A; Asher G; Gruss P; Lonai P; Oren M
EMBO J; 1997 Mar; 16(6):1381-90. PubMed ID: 9135153
[TBL] [Abstract][Full Text] [Related]
16. Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh).
Raafat A; Bargo S; Anver MR; Callahan R
Oncogene; 2004 Dec; 23(58):9401-7. PubMed ID: 15531924
[TBL] [Abstract][Full Text] [Related]
17. Efficient BLG-Cre mediated gene deletion in the mammary gland.
Selbert S; Bentley DJ; Melton DW; Rannie D; Lourenço P; Watson CJ; Clarke AR
Transgenic Res; 1998 Sep; 7(5):387-96. PubMed ID: 9859227
[TBL] [Abstract][Full Text] [Related]
18. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
19. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
20. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.
Parant J; Chavez-Reyes A; Little NA; Yan W; Reinke V; Jochemsen AG; Lozano G
Nat Genet; 2001 Sep; 29(1):92-5. PubMed ID: 11528400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
